medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2023, Number 2

<< Back Next >>

Cir Plast 2023; 33 (2)

Status of squamous cell carcinoma associated to breast implants: a systematic review of the literature

Telich-Tarriba JE, Martínez-Schulte A, Leyva-Vázquez LA, Telich-Vidal J

Language: Spanish
References: 30
Page: 67-72
PDF size: 199.69 Kb.


ABSTRACT

Squamous cell carcinoma associated to breast implants has attracted attention due its aggressiveness; although, the most recent reports show little more than a dozen cases worldwide. We present a systematic review of the literature of squamous cell carcinoma associated to breast implants. We performed a systematic review without language limits, using the terms: "breast implant", "breast capsule", "mammaplasty", "breast augmentation" and "squamous cell carcinoma". We included 15 articles with a total of 18 patients (17 women and 1 man); with an average age of 57 years (range 40 to 81 years); average time of 19 years (range 4 to 40 years) between the placement of the implant and the diagnosis of squamous cell carcinoma. The type of implants was heterogeneous. The symptoms became evident with enlargement (15 patients, 83.3%) and pain (13 patients, 72.2%). Treatment of the patients was predominantly surgical. We concluded that squamous cell carcinoma is a rare but highly aggressive tumor, whose etiology is not entirely clear. In the systematic review with the largest number of patients identified so far, we confirmed that the classic presentation is the development of late seroma with pain in patients who have had implants for a prolonged time. The disease does not appear to be limited to a single gender or anatomic site. Further studies and creation of records are needed to classify the risk factors of the disease, its treatment, and clinical outcomes better.


REFERENCES

  1. ISAPS International Survey on Aesthetic/Cosmetic Procedures performed in 2021. International Society of Aesthetic Plastic Surgery. [Accessed 27/02/2023] Available in: https://www.isaps.org/media/vdpdanke/isaps-global-survey_2021.pdf

  2. Buchanan PJ, Chopra VK, Walker KL, Rudolph R, Greco RJ. Primary squamous cell carcinoma arising from a breast implant capsule: a case report and review of the literature. Aesthet Surg J 2018; 38 (7): NP97-NP102. doi: 10.1093/asj/sjy092.

  3. Brinton LA, Brown SL. Breast implants and cancer. J Natl Cancer Inst 1997; 89 (18): 1341-1349.

  4. Molitor M, Mestak O, Kalinova? L, Krajcova? A, Mestak J. The history and safety of breast implants. Acta Chir Plast 2014; 56 (1-2):15-19.

  5. Rohrich RJ, Bellamy JL, Alleyne B. Assessing long-term outcomes in breast implant illness: the missing link? A systematic review. Plast Reconstr Surg 2022; 149 (4): 638e-645e.

  6. Coroneos CJ, Selber JC, Offodile AC 2nd, Butler CE, Clemens MW. US FDA breast implant post approval studies: long-term outcomes in 99,993 patients. Ann Surg 2019; 269 (1): 30-36.

  7. Naga HI, Mellia JA, Basta MN et al. Breast implant-associated anaplastic large-cell lymphoma: updated systematic review and analysis of treatment strategies. Plast Reconstr Surg 2022; 150 (4): 762-769.

  8. FDA Issues Safety Alert for Squamous Cell Carcinoma and Various Lymphomas in Scar Tissue around Breast Implants. [Accessed 27/02/2023] Available in: https://www.fda.gov/news-events/press-announcements/fda-issues-safety-alert-squamous-cell-carcinoma-and-various-lymphomas-scar-tissue-around-breast#:~:text=Today%2C%20the%20U.S.%20Food%20and,scar%20tissue%20around%20breast%20implants

  9. Paletta C, Paletta FX Jr, Paletta FX Sr. Squamous cell carcinoma following breast augmentation. Ann Plast Surg 1992; 29 (5): 425-429.

  10. Kitchen SB, Paletta CE, Shehadi SI, Bauer WC. Epithelialization of the lining of a breast implant capsule. Possible origins of squamous cell carcinoma associated with a breast implant capsule. Cancer 1994; 73 (5): 1449-1452.

  11. Behranwala KA, Nasiri N, Abdullah N, Trott PA, Gui GP. Squamous cell carcinoma of the breast: clinic-pathologic implications and outcome. Eur J Surg Oncol 2003; 29 (4): 386-389.

  12. Satgunaseelan L, Cheung D, Reddy J. Breast implant-associated squamous cell carcinoma – a rare long-term complication. Pathology 2015; 47 (Suppl 1): S72-S73.

  13. Zomerlei TA, Samarghandi A, Terando AM. Primary squamous cell carcinoma arising from a breast implant capsule. Plast Reconstr Surg Glob Open 2015; 3 (12): e586.

  14. Olsen DL, Keeney GL, Chen B, Visscher DW, Carter JM. Breast implant capsule-associated squamous cell carcinoma: a report of 2 cases. Hum Pathol 2017; 67: 94-100.

  15. Zhou Y M, Chaudhry H E, Shah A et al. Breast squamous cell carcinoma following breast augmentation. Cureus 2018; 10 (10): e3405.

  16. Alfaro L, Roca MJ, Jiménez A, Vázquez C. Breast implant-associated squamous cell carcinoma. Abstracts 31st European Congress of Pathology. Virchows Arch 2019; 475 (Suppl 1): 564.

  17. Camacho JP, Obaíd M, Bustos C et al. Squamous cell carcinoma as a result of likely industrial grade ruptured poly implant protheses silicone buttock implants. Aesthet Surg J Open Forum 2020; 2 (3): ojaa030.

  18. Zikiryakhodzhaev AD, Khakimova S, Rasskazova EA et al. Breast implant capsule-associated squamous cell carcinoma: case report. Malignant Tumors 2020; 10 (4): 30-37.

  19. Goldberg MT, Llaneras J, Willson TD et al. Squamous cell carcinoma arising in breast implant capsules. Ann Plast Surg 2021; 86 (3): 268-272.

  20. Liu Z, Liu C, Zhao C et al. Breast prosthetic implant-associated squamous cell carcinoma: a case report and literature review. Res Square. 2021. Available in: https://doi.org/10.21203/rs.3.rs-141167/v1

  21. Soni SE, Laun JC, Beard AS, Kuykendall LV. Breast implant capsule-associated squamous cell carcinoma during pregnancy: a mimicker of breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg 2022; 150 (4): 926e-928e.

  22. Whaley RD, Aldrees R, Dougherty RE, Prieto Granada C, Badve SS, Al Diffalha S. Breast implant capsule-associated squamous cell carcinoma: report of 2 patients. Int J Surg Pathol 2022; 30 (8): 900-907.

  23. Xia Z, Han B, Wang L et al. Breast implant-associated squamous cell carcinoma in a male patient: A case report and review of the medical literature. Front Surg 2023; 9: 983611. doi: 10.3389/fsurg.2022.983611.

  24. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 1997; 100 (2): 554-555.

  25. Yadav S, Yadav D, Zakalik D. Squamous cell carcinoma of the breast in the United States: incidence, demographics, tumor characteristics, and survival. Breast Cancer Res Treat 2017; 164 (1): 201-208.

  26. Vorstenbosch J, Chu JJ, Ariyan CE, McCarthy CM, Disa JJ, Nelson JA. Clinical implications and management of non-BIA-ALCL breast implant capsular pathology. Plast Reconstr Surg 2023; 151 (1): 20e-30e.

  27. van Diest PJ, Beekman WH, Hage JJ. Pathology of silicone leakage from breast implants. J Clin Pathol 1998; 51 (7): 493-497.

  28. Cervera M, Martínez-Regueira F, Sola J et al. Secuelas tras inyección ilegal de silicona líquida como técnica de aumento mamario: presentación de 2 casos. Cir Esp 2006; 80 (4): 227-229.

  29. Haac BE, White RE, Tirada N et al. Squamous cell carcinoma of the breast in the setting of a chronic breast abscess. ACS Case Reviews 2018; 2 (2): 14-19.

  30. ASPS statement on breast implant associated- squamous cell carcinoma (BIA-SCC). American Society of Plastic Surgeons. 2022.




2020     |     www.medigraphic.com